Skip to main content
SpringerLink
Log in

Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish

  • Original Paper
  • Published:
Transgenic Research Aims and scope Submit manuscript

Abstract

The activated cannabinoid receptor 1 (CB1R) is exclusively responsible for food intake and weight gain and regulates several pathological features associated with obesity in mammals. However, the precise role of CB1R in non-mammalian model systems is poorly understood. To investigate the functions of CB1R in zebrafish liver, we conditionally expressed CB1R proteins using a liver-specific Tetoff transgenic system. In this study, we found hepatic lipid accumulation in CB1R transgenic zebrafish (CB) without doxycycline treatment (−Dox) and a suppression of CB1R expression, resulting in the loss of lipid accumulation in the livers of CB fish that received doxycycline treatment (+Dox). Oil Red O (ORO)-stained hepatocytes were predominant in the liver buds of CB-Dox larvae, indicating that CB1R functionally promotes lipid accumulation during CB hepatogenesis. More than 73 % of CB-Dox adults showed increased lipid content, which leads, in turn, to steatosis. Liver histology and ORO staining of CB-Dox hepatocytes also indicated the accumulation of fatty droplets in the CB liver samples, consistent with the specific pathological features of liver steatosis or steatohepatitis. We also found that hepatic CB1R overexpression accompanies the stimulation of the lipogenic transcription factor SREBP-1c and its target enzymes, acetyl coenzyme-A carboxylase-1 (ACC1) and fatty acid synthase (FAS), and increases de novo fatty acid synthesis. This study is the first to report CB1R as a potential hepatic stimulator for zebrafish liver steatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Agudo J, Martin M, Roca C, Molas M, Bura AS, Zimmer A, Bosch F, Maldonado R (2010) Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia 53(12):2629–2640

    Article  PubMed  CAS  Google Scholar 

  • Anezaki Y, Ohshima S, Ishii H, Kinoshita N, Dohmen T, Kataoka E, Sato W, Iizuka M, Goto T, Sasaki J, Sasaki T, Suzuki A, Ohnishi H, Horie Y (2009) Sex difference in the liver of hepatocyte-specific Pten-deficient mice: a model of nonalcoholic steatohepatitis. Hepatol Res 39(6):609–618

    Article  PubMed  CAS  Google Scholar 

  • Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, Urbaschek R, Garcia N Jr, Sanyal AJ, Kunos G (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7(7):827–832

    Article  PubMed  CAS  Google Scholar 

  • Bellocchio L, Lafenetre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G (2010) Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 13(3):281–283

    Article  PubMed  CAS  Google Scholar 

  • Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63(4):908–914

    Article  PubMed  CAS  Google Scholar 

  • Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M (2007) Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology 190(4):441–448

    Article  PubMed  CAS  Google Scholar 

  • Brown MS, Goldstein JL (1998) Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake. Nutr Rev 56(2 Pt 2):S1–3; discussion S54–75

    Google Scholar 

  • Chen LJ, Hsu CC, Hong JR, Jou LK, Tseng HC, Wu JL, Liou YC, Her GM (2008) Liver-specific expression of p53-negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish. Dev Dyn 237(4):1070–1081

    Article  PubMed  CAS  Google Scholar 

  • Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139(4):1405–1415

    Article  PubMed  CAS  Google Scholar 

  • Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142(4):711–725 e716

    Google Scholar 

  • Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353(20):2121–2134

    Article  PubMed  CAS  Google Scholar 

  • Deveaux V, Cadoudal T, Ichigotani Y, Teixeira-Clerc F, Louvet A, Manin S, Nhieu JT, Belot MP, Zimmer A, Even P, Cani PD, Knauf C, Burcelin R, Bertola A, Le Marchand-Brustel Y, Gual P, Mallat A, Lotersztajn S (2009) Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS ONE 4(6):e5844

    Article  PubMed  Google Scholar 

  • Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8(5):585–589

    Article  PubMed  Google Scholar 

  • Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410(6830):822–825

    Article  PubMed  Google Scholar 

  • Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrie P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M (2007) Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46(1):122–129

    Article  PubMed  CAS  Google Scholar 

  • Harvey-Girard E, Giassi AC, Ellis W, Maler L (2012) Expression of the cannabinoid CB1 receptor in the gymnotiform fish brain and its implications for the organization of the teleost pallium. J Comp Neurol. doi:10.1002/cne.23212

  • Her GM, Chiang CC, Chen WY, Wu JL (2003) In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett 538(1–3):125–133

    Article  PubMed  CAS  Google Scholar 

  • Her GM, Cheng CH, Hong JR, Sundaram GS, Wu JL (2006) Imbalance in liver homeostasis leading to hyperplasia by overexpressing either one of the Bcl-2-related genes, zfBLP1 and zfMcl-1a. Dev Dyn 235(2):515–523

    Article  PubMed  CAS  Google Scholar 

  • Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, Chan SK, Pai WY (2011) Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 1811(9):536–548

    Article  PubMed  CAS  Google Scholar 

  • Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11(2):563–583

    PubMed  CAS  Google Scholar 

  • Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54(2):161–202

    Article  PubMed  CAS  Google Scholar 

  • Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128(3):742–755

    Article  PubMed  CAS  Google Scholar 

  • Lam CS, Rastegar S, Strahle U (2006) Distribution of cannabinoid receptor 1 in the CNS of zebrafish. Neuroscience 138(1):83–95

    Article  PubMed  CAS  Google Scholar 

  • Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L (2009) Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) 87(7):679–695

    Article  CAS  Google Scholar 

  • Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14(2):72–81

    Article  PubMed  CAS  Google Scholar 

  • McPartland JM, Glass M, Matias I, Norris RW, Kilpatrick CW (2007) A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio). Mol Genet Genomics 277(5):555–570

    Article  PubMed  CAS  Google Scholar 

  • Mendez-Sanchez N, Zamora-Valdes D, Pichardo-Bahena R, Barredo-Prieto B, Ponciano-Rodriguez G, Bermejo-Martinez L, Chavez-Tapia NC, Baptista-Gonzalez HA, Uribe M (2007) Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int 27(2):215–219

    Article  PubMed  CAS  Google Scholar 

  • Migliarini B, Carnevali O (2008) Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. Mol Cell Endocrinol 286 (1–2 Suppl 1):S12–S16

    Google Scholar 

  • Migliarini B, Carnevali O (2009) A novel role for the endocannabinoid system during zebrafish development. Mol Cell Endocrinol 299(2):172–177

    Article  PubMed  CAS  Google Scholar 

  • Migliarini B, Marucci G, Ghelfi F, Carnevali O (2006) Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics. FEBS Lett 580(8):1941–1945

    Article  PubMed  Google Scholar 

  • Nishio S, Gibert Y, Berekelya L, Bernard L, Brunet F, Guillot E, Le Bail JC, Sanchez JA, Galzin AM, Triqueneaux G, Laudet V (2012) Fasting induces CART down-regulation in the Zebrafish nervous system in a cannabinoid receptor 1-dependent manner. Mol Endocrinol 26(8):1316–1326

    Article  PubMed  CAS  Google Scholar 

  • Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tschop J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, Fekete C, Reizes O, Rohner-Jeanrenaud F, Tschop MH (2008) Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 57(11):2977–2991

    Article  PubMed  CAS  Google Scholar 

  • Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, Harvey-White J, Mackie K, Offertaler L, Wang L, Kunos G (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115(5):1298–1305

    PubMed  CAS  Google Scholar 

  • Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, Jeong WI, Batkai S, Marsicano G, Lutz B, Buettner C, Kunos G (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118(9):3160–3169

    Article  PubMed  CAS  Google Scholar 

  • Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389–462

    Article  PubMed  CAS  Google Scholar 

  • Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90(1):45–60

    Article  PubMed  CAS  Google Scholar 

  • Provost E, Rhee J, Leach SD (2007) Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos. Genesis 45(10):625–629

    Article  PubMed  CAS  Google Scholar 

  • Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G (2012) Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res 159(6):477–486

    Article  PubMed  CAS  Google Scholar 

  • Shieh YS, Chang YS, Hong JR, Chen LJ, Jou LK, Hsu CC, Her GM (2010) Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus × protein in zebrafish. Biochim Biophys Acta 1801(7):721–730

    Article  PubMed  CAS  Google Scholar 

  • Stincic TL, Hyson RL (2011) The localization and physiological effects of cannabinoid receptor 1 in the brain stem auditory system of the chick. Neuroscience 194:150–159

    Article  PubMed  CAS  Google Scholar 

  • Tam J, Vemuri VK, Liu J, Batkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G (2010) Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120(8):2953–2966

    Article  PubMed  CAS  Google Scholar 

  • Tedesco L, Valerio A, Cervino C, Cardile A, Pagano C, Vettor R, Pasquali R, Carruba MO, Marsicano G, Lutz B, Pagotto U, Nisoli E (2008) Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57(8):2028–2036

    Article  PubMed  CAS  Google Scholar 

  • Teixeira-Clerc F, Belot MP, Manin S, Deveaux V, Cadoudal T, Chobert MN, Louvet A, Zimmer A, Tordjmann T, Mallat A, Lotersztajn S (2010) Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 52(3):1046–1059

    Article  PubMed  CAS  Google Scholar 

  • Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5):1836–1846

    Article  PubMed  CAS  Google Scholar 

  • Valenti M, Cottone E, Martinez R, De Pedro N, Rubio M, Viveros MP, Franzoni MF, Delgado MJ, Di Marzo V (2005) The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J Neurochem 95(3):662–672

    Article  PubMed  CAS  Google Scholar 

  • Westerbacka J, Kotronen A, Fielding BA, Wahren J, Hodson L, Perttila J, Seppanen-Laakso T, Suortti T, Arola J, Hultcrantz R, Castillo S, Olkkonen VM, Frayn KN, Oresic M, Yki-Jarvinen H (2010) Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology 139(6):1961–1971 e1961

    Google Scholar 

  • Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112(1):91–100

    PubMed  CAS  Google Scholar 

  • Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J, Fan W, Li Q, Wang Q, Zhong D, Miao X (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171(1):31–38

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a Taiwan National Science Council grant (Grant No. NSC 101-2313-B-019-003) and by a Ministry of Education Grant for Promoting Academic Excellence awarded to Guor Mour Her.

Author information

Authors and Affiliations

  1. Institute of Bioscience and Biotechnology, National Taiwan Ocean University, 2 Pei Ning Road, Keelung, 20224, Taiwan

    Wan-Yu Pai, Chi-Yu Lai, Trent-Zarng Chang, Yu-Lun Tsai & Guor Mour Her

  2. Department of Radiology, Buddhist Tzu Chi General Hospital, Taichung Branch, Taichung, Taiwan

    Chia-Chun Hsu

  3. Center of Excellence for Marine Bioenvironment and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan

    Guor Mour Her

Authors
  1. Wan-Yu Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chia-Chun Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chi-Yu Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Trent-Zarng Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-Lun Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guor Mour Her
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guor Mour Her.

Additional information

Wan-Yu Pai, Chia-Chun Hsu have equal research contributions in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pai, WY., Hsu, CC., Lai, CY. et al. Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish. Transgenic Res 22, 823–838 (2013). https://doi.org/10.1007/s11248-012-9685-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11248-012-9685-0

Keywords

Search

Navigation